557 related articles for article (PubMed ID: 33004602)
1. CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Edén A; Kanberg N; Gostner J; Fuchs D; Hagberg L; Andersson LM; Lindh M; Price RW; Zetterberg H; Gisslén M
Neurology; 2021 Jan; 96(2):e294-e300. PubMed ID: 33004602
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
Jarius S; Pache F; Körtvelyessy P; Jelčić I; Stettner M; Franciotta D; Keller E; Neumann B; Ringelstein M; Senel M; Regeniter A; Kalantzis R; Willms JF; Berthele A; Busch M; Capobianco M; Eisele A; Reichen I; Dersch R; Rauer S; Sandner K; Ayzenberg I; Gross CC; Hegen H; Khalil M; Kleiter I; Lenhard T; Haas J; Aktas O; Angstwurm K; Kleinschnitz C; Lewerenz J; Tumani H; Paul F; Stangel M; Ruprecht K; Wildemann B;
J Neuroinflammation; 2022 Jan; 19(1):19. PubMed ID: 35057809
[TBL] [Abstract][Full Text] [Related]
3. Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
Edén A; Grahn A; Bremell D; Aghvanyan A; Bathala P; Fuchs D; Gostner J; Hagberg L; Kanberg N; Kanjananimmanont S; Lindh M; Misaghian S; Nilsson S; Schöll M; Sigal G; Stentoft E; Studahl M; Yilmaz A; Wang M; Stengelin M; Zetterberg H; Gisslén M
JAMA Netw Open; 2022 May; 5(5):e2213253. PubMed ID: 35604688
[TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
[TBL] [Abstract][Full Text] [Related]
5. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid in COVID-19: A systematic review of the literature.
Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR
J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
Espíndola OM; Brandão CO; Gomes YCP; Siqueira M; Soares CN; Lima MASD; Leite ACCB; Torezani G; Araujo AQC; Silva MTT
Int J Infect Dis; 2021 Jan; 102():155-162. PubMed ID: 33127503
[TBL] [Abstract][Full Text] [Related]
8. Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in the Serum and Cerebrospinal Fluid of Patients With Coronavirus Disease 2019 and Neurological Symptoms.
Cunningham JL; Virhammar J; Rönnberg B; Dopico XC; Kolstad L; Albinsson B; Kumlien E; Nääs A; Klang A; Westman G; Zetterberg H; Frithiof R; Lundkvist Å; Karlsson Hedestam GB; Rostami E
J Infect Dis; 2022 Mar; 225(6):965-970. PubMed ID: 33744954
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical biomarkers to study CNS effects of COVID-19: A narrative review and synthesis.
Edén A; Simrén J; Price RW; Zetterberg H; Gisslén M
J Neurochem; 2021 Oct; 159(1):61-77. PubMed ID: 34170549
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients.
Lersy F; Benotmane I; Helms J; Collange O; Schenck M; Brisset JC; Chammas A; Willaume T; Lefebvre N; Solis M; Hansmann Y; Fabacher T; Caillard S; Mertes PM; Pottecher J; Schneider F; Meziani F; Fafi-Kremer S; Kremer S
J Infect Dis; 2021 Feb; 223(4):600-609. PubMed ID: 33249438
[TBL] [Abstract][Full Text] [Related]
11. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection.
Peluso MJ; Sans HM; Forman CA; Nylander AN; Ho HE; Lu S; Goldberg SA; Hoh R; Tai V; Munter SE; Chenna A; Yee BC; Winslow JW; Petropoulos CJ; Martin JN; Kelly JD; Durstenfeld MS; Hsue PY; Hunt PW; Greene M; Chow FC; Hellmuth J; Henrich TJ; Glidden DV; Deeks SG
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35701186
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients.
Guilmot A; Maldonado Slootjes S; Sellimi A; Bronchain M; Hanseeuw B; Belkhir L; Yombi JC; De Greef J; Pothen L; Yildiz H; Duprez T; Fillée C; Anantharajah A; Capes A; Hantson P; Jacquerye P; Raymackers JM; London F; El Sankari S; Ivanoiu A; Maggi P; van Pesch V
J Neurol; 2021 Mar; 268(3):751-757. PubMed ID: 32734353
[TBL] [Abstract][Full Text] [Related]
13. A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19.
Tandon M; Kataria S; Patel J; Mehta TR; Daimee M; Patel V; Prasad A; Chowdhary AA; Jaiswal S; Sriwastava S
Int J Infect Dis; 2021 Mar; 104():390-397. PubMed ID: 33434662
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity.
Virhammar J; Nääs A; Fällmar D; Cunningham JL; Klang A; Ashton NJ; Jackmann S; Westman G; Frithiof R; Blennow K; Zetterberg H; Kumlien E; Rostami E
Eur J Neurol; 2021 Oct; 28(10):3324-3331. PubMed ID: 33369818
[TBL] [Abstract][Full Text] [Related]
15. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
16. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement.
Senel M; Abu-Rumeileh S; Michel D; Garibashvili T; Althaus K; Kassubek J; Otto M
Eur J Neurol; 2020 Nov; 27(11):2378-2380. PubMed ID: 32781484
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses.
Pilotto A; Masciocchi S; Volonghi I; De Giuli V; Caprioli F; Mariotto S; Ferrari S; Bozzetti S; Imarisio A; Risi B; Premi E; Benussi A; Focà E; Castelli F; Zanusso G; Monaco S; Stefanelli P; Gasparotti R; Zekeridou A; McKeon A; Ashton NJ; BlennoW K; Zetterberg H; Padovani A
Clin Infect Dis; 2021 Nov; 73(9):e3019-e3026. PubMed ID: 33395482
[TBL] [Abstract][Full Text] [Related]
18. Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients.
Zingaropoli MA; Iannetta M; Piermatteo L; Pasculli P; Latronico T; Mazzuti L; Campogiani L; Duca L; Ferraguti G; De Michele M; Galardo G; Pugliese F; Antonelli G; Andreoni M; Sarmati L; Lichtner M; Turriziani O; Ceccherini-Silberstein F; Liuzzi GM; Mastroianni CM; Ciardi MR
Cells; 2022 Aug; 11(16):. PubMed ID: 36010557
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications.
Kanberg N; Grahn A; Stentoft E; Bremell D; Yilmaz A; Studahl M; Nilsson S; Schöll M; Gostner JM; Blennow K; Zetterberg H; Padmanabhan N; Cohen R; Misaghian S; Romero D; Campbell C; Mathew A; Wang M; Sigal G; Stengelin M; Edén A; Gisslén M
J Infect Dis; 2024 Feb; 229(2):493-501. PubMed ID: 37874918
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study.
Nersesjan V; Amiri M; Nilsson AC; Wamberg C; Jensen VVS; Petersen CB; Hejl AM; Lebech AM; Theut AM; Jørgensen CS; Blaabjerg M; Benros ME; Kondziella D
Brain Commun; 2023; 5(5):fcad274. PubMed ID: 37908236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
